IDEAL EXTRACT Trademark

Trademark Overview

On Thursday, April 27, 2017, a trademark application was filed for IDEAL EXTRACT with the United States Patent and Trademark Office. The USPTO has given the IDEAL EXTRACT trademark a serial number of 87428364. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, July 9, 2020. This trademark is owned by Ananda Scientific, Inc.. The IDEAL EXTRACT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceuticals for the treatment of diabetes, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, cardiac disorders, neuropathic pain, anxiety, mood disorders, epilepsy, sleep disorders, muscular diseases including muscular dystrophy and Parkinson's disease, and neurological disorders; therapeutics, namely, sprays for weight control, appetite suppression, muscle relaxation, and sleep disorders; nutritional supplements
ideal extract

General Information

Serial Number87428364
Word MarkIDEAL EXTRACT
Filing DateThursday, April 27, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, July 9, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"EXTRACT"
Goods and ServicesPharmaceutical preparations, namely, pharmaceuticals for the treatment of diabetes, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, cardiac disorders, neuropathic pain, anxiety, mood disorders, epilepsy, sleep disorders, muscular diseases including muscular dystrophy and Parkinson's disease, and neurological disorders; therapeutics, namely, sprays for weight control, appetite suppression, muscle relaxation, and sleep disorders; nutritional supplements

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 3, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAnanda Scientific, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDraper, UT 84020

Trademark Events

Event DateEvent Description
Thursday, July 9, 2020EXPARTE APPEAL TERMINATED
Thursday, July 9, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, July 9, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, July 1, 2020ASSIGNED TO EXAMINER
Sunday, November 10, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, November 10, 2019NON-FINAL ACTION E-MAILED
Sunday, November 10, 2019NON-FINAL ACTION WRITTEN
Friday, October 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 28, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 28, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 16, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 16, 2019NON-FINAL ACTION E-MAILED
Tuesday, April 16, 2019NON-FINAL ACTION WRITTEN
Friday, February 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 7, 2019ASSIGNED TO LIE
Monday, February 4, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, February 4, 2019EX PARTE APPEAL-INSTITUTED
Monday, February 4, 2019JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, February 4, 2019EXPARTE APPEAL RECEIVED AT TTAB
Friday, November 2, 2018ASSIGNED TO EXAMINER
Thursday, August 2, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, August 2, 2018FINAL REFUSAL E-MAILED
Thursday, August 2, 2018FINAL REFUSAL WRITTEN
Wednesday, August 1, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 31, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 31, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 31, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 31, 2018NON-FINAL ACTION E-MAILED
Wednesday, January 31, 2018NON-FINAL ACTION WRITTEN
Tuesday, January 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 29, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 29, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 28, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, July 28, 2017PRIORITY ACTION E-MAILED
Friday, July 28, 2017PRIORITY ACTION WRITTEN
Tuesday, July 25, 2017ASSIGNED TO EXAMINER
Wednesday, May 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 1, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

extract ideal disorders muscular namely sleep disease therapeutics neurological dystrophy diseases including